Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 34fludarabine phosphate 32Mycophenolic Acid 27Whole-Body Irradiation 21Peripheral Blood Stem Cell Transplantation 21Tacrolimus 19Melphalan 18Cyclosporine 17fludarabine 16Busulfan 16Antilymphocyte Serum 16Filgrastim 12Cord Blood Stem Cell Transplantation 9Methotrexate 8Radiotherapy 7Methylprednisolone 6Granulocyte Colony-Stimulating Factor 6Sirolimus 5Rituximab 5Epoetin Alfa 5Etoposide 4Cytarabine 4Alemtuzumab 4thymoglobulin 3Therapeutics 3Stem Cell Transplantation 3Darbepoetin alfa 3Clofarabine 3CT-P10 3Bortezomib 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hodgkin Disease × Health Promotion × Classical hematology × Clear all
NCT05972577 2026-04-06

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

Ohio State University Comprehensive Cancer Center

Phase NA Completed
30 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡